Search PDMR transactions

Notifier
Name
Staffan Strömberg
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Staffan Strömberg
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Infant Bacterial Therapeutics AB
LEI
2138008KVBXCRJGP6Z26
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Infant Bacterial Therapeutics AB Option 2020/2024 Acquisition 39,851 Quantity 4.8644 SEK 03/12/2020 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Infant Bacterial Therapeutics AB Option 2020/2024 Acquisition 03/12/2020 Outside a trading venue 39,851 (Quantity) 4.8644 SEK
<< Back